Stay updated on iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial
Sign up to get notified when there's something new on the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page.

Latest updates to the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision log updated to v3.5.0 and removal of v3.4.3; no changes to study details or eligibility are indicated.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedA site update introduces Revision: v3.4.2 and removes the lapse-in-government-funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedA site-wide funding-status notice was added, informing users about the lapse in government funding and the open status of the NIH Clinical Center. The site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check79 days agoChange DetectedA glossary display option was added, and page metadata labels were updated (including Revision: v3.4.0 and capitalization tweaks to QC-related text).SummaryDifference0.2%

Stay in the know with updates to iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page.